GMS Ventures & Investments
CIK 1804598 · last filed 2026-06-01
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$26.95M
Companies
2
Total Filings
12
Lifetime Open-Market Net
$66.72M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| OTLK | Director | 22,092,068 | $1.22 | $26.95M | $10.00M | 7 | 2026-06-01 |
| Outlook Therapeutics, Inc. (OTLKW) Delisted | Director | 27,982,529 | $0.03 | $839.5K | $56.72M | 5 | 2022-02-01 |
Recent Filings · Page 2 of 2
12 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-02-02 | Outlook Therapeutics, Inc. (OTLKW) Delisted | Buy (P) | +16,720,000 | $16.72M | EDGAR |
| 2020-02-27 | Outlook Therapeutics, Inc. (OTLKW) Delisted | Grant (A) | +4,921,260 | $5.00M | EDGAR |
Showing 11–12 of 12
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.